Laznicek M - Search Results

1

Distribution and elimination characteristics of 111In-DTPA-D-phe1-octreotide and 111In-DTPA-L-phe1-octreotide in rats.

Laznickova A, Laznicek M, Trejtnar F, Melicharova L, Suzuki KH, Akizawa H, Arano Y, Yokoyama A. Laznickova A, et al. Among authors: laznicek m. Eur J Drug Metab Pharmacokinet. 2002 Jan-Mar;27(1):37-43. doi: 10.1007/BF03190403. Eur J Drug Metab Pharmacokinet. 2002. PMID: 11996325

2

Lanreotide labeled with 99mTc: preparation, preclinical testing and comparison with (111)In-DTPA-octreotide.

Laznicek M, Laznickova A, Trejtnar F, Lorenc P, Varvarigou A, Bouziotis P, Archimandritis S. Laznicek M, et al. Anticancer Res. 2002 Jul-Aug;22(4):2125-30. Anticancer Res. 2002. PMID: 12174893

3

Comparison of 99mTc-mercaptoacetyltriglycine and [131I]-o-iodohippurate elimination in perfused rat kidney.

Trejtnar F, Laznicek M, Laznickova A. Trejtnar F, et al. Among authors: laznicek m. Nucl Med Biol. 2003 Jan;30(1):45-9. doi: 10.1016/s0969-8051(02)00377-3. Nucl Med Biol. 2003. PMID: 12493542

4

99mTc demotate 1: biodistribution and elimination characteristics in rats.

Kopecky M, Trejtnar F, Laznicek M, Laznickova A, Semecky V, Maina T, Nock B. Kopecky M, et al. Among authors: laznicek m. Nucl Med Commun. 2005 Jun;26(6):549-54. doi: 10.1097/00006231-200506000-00011. Nucl Med Commun. 2005. PMID: 15891599

5

Biodistribution and elimination characteristics of two 111In-labeled CCK-2/gastrin receptor-specific peptides in rats.

Trejtnar F, Laznicek M, Laznickova A, Kopecky M, Petrik M, Béhé M, Schmidt J, Maecke H, Maina T, Nock B. Trejtnar F, et al. Among authors: laznicek m. Anticancer Res. 2007 Mar-Apr;27(2):907-12. Anticancer Res. 2007. PMID: 17465219 Free article.

6

Comparison of 111In-DOTA-NOC and 111I-DOTA-TATE distribution in the target and dose-limiting tissues: conflicting results in vitro and in vivo.

Cihlo J, Melicharová L, Petrik M, Laznickova A, Laznicek M. Cihlo J, et al. Among authors: laznicek m. Anticancer Res. 2008 Jul-Aug;28(4B):2189-95. Anticancer Res. 2008. PMID: 18751394 Free article.

7

Different radioactivity uptake between somatostatin analogues labelled with ¹¹¹In and ⁹⁰/⁸⁸Y in rat kidney.

Laznicek M, Laznickova A. Laznicek M, et al. Anticancer Res. 2012 Mar;32(3):815-22. Anticancer Res. 2012. PMID: 22399599

8

Distribution, elimination, and renal handling of (99m)technetium-Demogastrin 1.

Trejtnar F, Laznickova A, Laznicek M, Novy Z, Maina T, Nock BA, Behe M. Trejtnar F, et al. Among authors: laznicek m. Cancer Biother Radiopharm. 2012 Mar;27(2):169-74. doi: 10.1089/cbr.2011.1008. Cancer Biother Radiopharm. 2012. PMID: 22409267

9

Preclinical evaluation of gastrin derivatives labelled with 111In: radiolabelling, affinity profile and pharmacokinetics in rats.

Melicharova L, Laznickova A, Laznicek M. Melicharova L, et al. Among authors: laznicek m. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014 Dec;158(4):544-51. doi: 10.5507/bp.2013.064. Epub 2013 Sep 27. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014. PMID: 24108197 Free article.

10

The effect of molecular weight on the biodistribution of hyaluronic acid radiolabeled with 111In after intravenous administration to rats.

Svanovsky E, Velebny V, Laznickova A, Laznicek M. Svanovsky E, et al. Among authors: laznicek m. Eur J Drug Metab Pharmacokinet. 2008 Jul-Sep;33(3):149-57. doi: 10.1007/BF03191112. Eur J Drug Metab Pharmacokinet. 2008. PMID: 19007040

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters